Free Trial
→ Think you missed gold’s boom? Think again (From Investors Alley) (Ad)

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Global X Education ETF stock logo
EDUT
Global X Education ETF
$20.54
$20.54
$18.40
▼
$25.52
$2.67M0.87477 shsN/A
KSEA
KraneShares Rockefeller Ocean Engagement ETF
$27.67
$27.47
$24.23
▼
$29.02
$1.38M0.88148 shsN/A
LMBO
Direxion Daily Crypto Industry Bull 2X Shares
$22.26
+0.6%		$18.13
$10.41
▼
$33.86
$3.90MN/A4,902 shs1,814 shs
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
$7.38
$7.38
$5.87
▼
$11.83
$2.21M0.923,034 shsN/A
Ten Starter Stocks For Beginners to Buy Now Cover
Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Global X Education ETF stock logo
EDUT
Global X Education ETF
0.00%0.00%0.00%0.00%0.00%
KSEA
KraneShares Rockefeller Ocean Engagement ETF
0.00%0.00%0.00%+3.32%+4.42%
LMBO
Direxion Daily Crypto Industry Bull 2X Shares
+0.63%+9.87%+18.28%+38.09%+2,225,999,900.00%
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Global X Education ETF stock logo
EDUT
Global X Education ETF
N/AN/AN/AN/AN/AN/AN/AN/A
KSEA
KraneShares Rockefeller Ocean Engagement ETF
N/AN/AN/AN/AN/AN/AN/AN/A
LMBO
Direxion Daily Crypto Industry Bull 2X Shares
N/AN/AN/AN/AN/AN/AN/AN/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Global X Education ETF stock logo
EDUT
Global X Education ETF
2.27
Hold$20.54N/A
KSEA
KraneShares Rockefeller Ocean Engagement ETF
0.00
N/AN/AN/A
LMBO
Direxion Daily Crypto Industry Bull 2X Shares
2.78
Moderate Buy$22.26N/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Global X Education ETF stock logo
EDUT
Global X Education ETF
N/AN/AN/AN/AN/AN/A
KSEA
KraneShares Rockefeller Ocean Engagement ETF
N/AN/AN/AN/AN/AN/A
LMBO
Direxion Daily Crypto Industry Bull 2X Shares
N/AN/AN/AN/AN/AN/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Global X Education ETF stock logo
EDUT
Global X Education ETF
N/AN/A27.61∞N/AN/AN/AN/AN/A
KSEA
KraneShares Rockefeller Ocean Engagement ETF
N/AN/A22.33∞N/AN/AN/AN/AN/A
LMBO
Direxion Daily Crypto Industry Bull 2X Shares
N/AN/A32.27∞N/AN/AN/AN/AN/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/AN/A17.02∞N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Global X Education ETF stock logo
EDUT
Global X Education ETF
$0.271.31%N/AN/AN/A
KSEA
KraneShares Rockefeller Ocean Engagement ETF
$0.230.83%N/AN/AN/A
LMBO
Direxion Daily Crypto Industry Bull 2X Shares
$0.090.40%N/AN/AN/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/A0.12%N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Global X Education ETF stock logo
EDUT
Global X Education ETF
N/A
KSEA
KraneShares Rockefeller Ocean Engagement ETF
N/A
LMBO
Direxion Daily Crypto Industry Bull 2X Shares
N/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/A

Insider Ownership

CompanyInsider Ownership
Global X Education ETF stock logo
EDUT
Global X Education ETF
N/A
KSEA
KraneShares Rockefeller Ocean Engagement ETF
N/A
LMBO
Direxion Daily Crypto Industry Bull 2X Shares
N/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Global X Education ETF stock logo
EDUT
Global X Education ETF
147,000130,000N/ANot Optionable
KSEA
KraneShares Rockefeller Ocean Engagement ETF
N/A50,002N/ANot Optionable
LMBO
Direxion Daily Crypto Industry Bull 2X Shares
N/A175,001N/AN/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/A300,000N/AOptionable

Recent News About These Companies

CHOP, Penn advance CRISPR gene editing with fast-developed treatment for an infant with a rare disease
May 15, 2025  |  msn.comhttps://www.msn.com/en-us/science/biology/chop-penn-advance-crispr-gene-editing-with-fast-developed-treatment-for-an-infant-with-a-rare-disease/ar-AA1EQMQr
Nobel Prize winners convince court to revive CRISPR patent dispute
May 12, 2025  |  reuters.comhttps://www.reuters.com/legal/government/nobel-prize-winners-convince-court-revive-crispr-patent-dispute-2025-05-12/
Biotech investors: Stop expecting CRISPR science to make big leaps
April 14, 2025  |  statnews.comS
AI and gene editing promise ‘bespoke proteins’ for biotech
October 8, 2024  |  siliconrepublic.comS
Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
October 2, 2024  |  yahoo.comhttps://www.yahoo.com/tech/weight-loss-drug-breakthroughs-gene-090000589.html
K-12 Genome Editing at Only $2 a Pop
September 27, 2024  |  yahoo.comhttps://www.yahoo.com/tech/k-12-genome-editing-only-144035108.html
Vertex Stock: Came For CF Drugs, Staying For Gene Therapy
August 2, 2024  |  seekingalpha.comhttps://seekingalpha.com/article/4709620-vertex-stock-came-for-cf-drugs-staying-for-gene-therapy
CRISPR can treat common form of inherited blindness, early data hint
May 15, 2024  |  msn.comhttps://www.msn.com/en-gb/health/other/crispr-can-treat-common-form-of-inherited-blindness-early-data-hint/ar-BB1mrQQG
CRISPR gene editing: in summary
March 27, 2024  |  biotechniques.comB
CRISPR Technology Takes Center Stage at SXSW 2024 for the First Time
March 8, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/crispr-technology-takes-center-stage-at-sxsw-2024-for-the-first-time-1033147575
Intellia Collaborates With ReCode To Develop Gene Therapy For Cystic Fibrosis
February 15, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/intellia-collaborates-with-recode-to-develop-gene-therapy-for-cystic-fibrosis-1033071688
CRISPR Technology: Unveiling the Breakthrough in Gene Editing and Its Far-Reaching Implications
January 18, 2024  |  techbullion.comT
Here's Why CRISPR Therapeutics Stock Rose 54% Last Year
January 15, 2024  |  msn.comhttps://www.msn.com/en-us/money/other/here-s-why-crispr-therapeutics-stock-rose-54-last-year/ar-AA1n1jau
Gene editing is now a medical reality
December 8, 2023  |  news.yahoo.comhttps://news.yahoo.com/gene-editing-now-medical-reality-224326223.html
FDA approves first use of CRISPR gene editing to treat sickle cell disease
December 8, 2023  |  news.yahoo.comhttps://news.yahoo.com/fda-approves-first-crispr-gene-173254689.html
FDA Approves First Gene-Editing Cell Therapy For Sickle Cell Disease, An Inherited Blood Disorder
December 8, 2023  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/fda-approves-first-gene-editing-cell-therapy-for-sickle-cell-disease-an-inherited-blood-disorder-1032886628
Gene Editing Will Change Medicine—and Maybe Health Investing Too
November 24, 2023  |  msn.comhttps://www.msn.com/en-us/health/other/gene-editing-will-change-medicine-and-maybe-health-investing-too/ar-AA1ksQev
CRISPR/Cas9 unlocks TuMV resistance in Chinese cabbage: A leap forward in genome-edited plant breeding
November 23, 2023  |  phys.orgP
Is CRISPR Therapeutics the Best Gene-Editing Stock?
November 22, 2023  |  msn.comhttps://www.msn.com/en-us/money/other/is-crispr-therapeutics-the-best-gene-editing-stock/ar-AA1klNrx
Three people were gene-edited in an effort to cure their HIV. The result is unknown.
November 16, 2023  |  technologyreview.comT

Media Sentiment Over Time

Global X Education ETF stock logo

Global X Education ETF NASDAQ:EDUT

$20.54 0.00 (0.00%)
As of 06/20/2025

The Global X Education ETF (EDUT) is an exchange-traded fund that is based on the Indxx Global Education Thematic index, a market-cap-weighted index of global companies providing products and services that facilitate education. EDUT was launched on Jul 10, 2020 and is managed by Global X.

KraneShares Rockefeller Ocean Engagement ETF NYSEARCA:KSEA

$27.67 0.00 (0.00%)
As of 05/29/2025

The KraneShares Rockefeller Ocean Engagement ETF (KSEA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is actively managed, investing in companies located around the world whose business activities are perceived to be at the forefront of sustainable marine initiatives. Holdings will include companies from diverse sectors and market capitalization KSEA was launched on Sep 12, 2023 and is issued by KraneShares.

Direxion Daily Crypto Industry Bull 2X Shares NYSEARCA:LMBO

$22.26 +0.14 (+0.63%)
As of 06/25/2025 04:10 PM Eastern

The Direxion Daily Crypto Industry Bull 2X Shares (LMBO) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks 2x the daily price movements of a market cap-weighted index of US companies involved in blockchain technology, NFT, decentralized finance, and digital asset mining hardware. LMBO was launched on Jul 17, 2024 and is issued by Direxion.

Kelly CRISPR & Gene Editing Technology ETF stock logo

Kelly CRISPR & Gene Editing Technology ETF NASDAQ:XDNA

$7.38 0.00 (0.00%)
As of 06/24/2025

The Strategic CRISPR & Gene Editing Technology ETF (XDNA) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market-cap-weighted index of companies in developed markets that focus on the advancements in DNA modification technology. XDNA was launched on Jan 12, 2022 and is managed by Kelly.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas